openPR Logo
Press release

Clinical Trial Management System Market Top Companies - Bio Clinica Inc., Bio-Optronics, Inc., DataTrak Internationals, Inc., DSG Inc., Forte Research Systems Inc., MasterControl Inc., Medidata Solutions, Inc., MedNet Solutions, Inc.

04-03-2020 01:26 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Clinical Trial Management System Market

Clinical Trial Management System Market

Clinical Trial Management System Market will exceed USD 2.5 billion by 2025; as per a new research report. Increasing demand for contract research organizations for conducting clinical trials will augment the clinical trial management systems business growth over the analysis period. Benefits associated with outsourcing clinical trials including on time delivery, reduced cycle times and decreased administrative costs will foster industry growth. Use of clinical trials management systems (CTMS) in clinical trial has increased ability to deal with problems and produce effective results thereby, increasing its adoption in healthcare and pharmaceutical industries.

Enhanced R&D expenditure in life sciences and clinical research industries will spur business growth in coming years. Focus of pharmaceutical and biotechnology companies on new drug development has led to increased funding for clinical trials. Government organizations such as National Institute of health (NIH) funds various biotechnology and pharmaceutical projects. For instance, clinical research NIH funding increased; it was USD 11,087 in the year 2014 and augmented to USD 12,695 in year 2017. Increase in R&D spending in clinical studies will enhance adoption of CTMS for effective management of clinical trials.

Request sample copy of this report @

Cloud based solutions segment will show lucrative CAGR of 16.3% during the analysis timeframe. Growing urge of clinical trial organizations to adopt technologically upgraded software and solutions factor is expected to drive the healthcare cloud-based solutions segment over the forthcoming years. Demand for cloud computing solutions is specifically high in developing countries due to increasing number of clinical trials. Furthermore, maximum flexibility and data integrity offered by cloud based systems to the users will positively influence the segmental growth.

Clinical research organizations segment held 30.9% revenue share in 2018 and will show lucrative growth over the analysis timeframe. Escalated R&D expenditure by life science and clinical research industries will spur the revenue size. Outsourcing of clinical trials enabling pharmaceutical and biopharmaceutical companies to focus on their primary function of manufacturing and marketing of several pharmaceutical products will further fuel industry growth.

Software segment is anticipated to witness 14.0% CAGR during the upcoming years. Demand for CTMS software in clinical trials to reorganize document management procedures and deliver immediate admittance to the clinical trial documentation will favor segmental growth. Moreover, technological advancement in software systems will further augment business growth.

Make Inquiry about this report @

Enterprise based segment dominated the product segment with USD 805.7 million in 2018. Enterprise based CTMS enables faster access to subject data, patient recruitment, data capture & exchange, and speeds up the protocol design. Ability of these systems to emphasize on targeted patient population and indication, investigator performance and improved patient safety to allow predictable trial execution and reduce cycle cost and time will boost segmental growth.

North America clinical trial management systems market accounted for the 45.1% revenue share in 2018 and is expected to show lucrative growth during forecast period. High growth is attributed to presence of well-established healthcare infrastructure as well as huge number of clinical trials conducted in the region. Increasing support from government organizations such as NIH will surge the number of clinical trials thereby augmenting the demand for CTM systems. Moreover, presence of majority of pharmaceutical and biotechnology companies in the region will further spur regional industry size.

Asia-Pacific clinical trial management systems market will show fastest CAGR of 14.5% during the analysis timeframe. Growing number of companies for outsourcing clinical trials in emerging economies such as China, India and South Korea will impel business growth. Low operating costs for conducting clinical trials in these countries coupled with several government initiatives to develop infrastructure for clinical research will accelerate the regional growth.

Prominent industry players involved in clinical trial management system market are Bio-Optronics, MedNet Solutions, DataTrak Internationals, Bio Clinica, Forte Research Systems, MasterControl, Oracle, DSG, Omnicomm Systems, Medidata Solutions, Merge Healthcare (IBM Watson), Veeva Systems and Parexel Informatics. These key industry players are focusing on strategic alliances, new software development and collaborations to capitalize on market opportunities. For instance, in February 2018, Oracle launched a data marketing program and an advanced training on data, to help companies, shift to a digital platform and enhances company's market position.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management System Market Top Companies - Bio Clinica Inc., Bio-Optronics, Inc., DataTrak Internationals, Inc., DSG Inc., Forte Research Systems Inc., MasterControl Inc., Medidata Solutions, Inc., MedNet Solutions, Inc. here

News-ID: 1998365 • Views:

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases

More Releases for Clinica

Clinical Trial Management System CTMS Market to hit US$ 2478.15 million, Globall …
Global clinical trial management system (CTMS) market was valued at US$ 727.54 million in 2021 and is expected to reach US$ 2478.15 million by 2030, growing at an estimated CAGR of 14.6% over the forecast period. A New Market study by Absolute Markets Insights on the Global Clinical Trial Management System CTMS Market Report offers an in-house analysis of global economic conditions and related economic factors and indicators to evaluate their
Clinical Trial Management System Market Projection 2025 | Bio Clinica, Medidata …
Clinical Trial Management System Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges. Constant need for conducting clinical trials and growing expenditures on clinical studies will stir the demand for clinical trial management systems (CTMS) in the coming years.
Global Big Data Analytics in Healthcare Market, by Analytics type (Descriptive A …
Global Big Data Analytics in Healthcare Market was valued at US$ 23.93 million in 2019 and is projected to reach US$ 81.35 million by 2025, at a CAGR of 19.1% during the forecast period. A surge in the demand for analytics solutions for citizen health management, increase in the adoption of cloud analytics among several end users, growing need for business intelligence to optimize health administration & strategy, lack of
Healthcare Services Market by Profiling Key Players AAC Holdings, Abano Healthca …
The global healthcare services Market reached a value of nearly $6,707.3 billion in 2018, having grown at a compound annual growth rate (CAGR) of +7.6% since 2014, and is expected to grow at a CAGR of +9.3% to nearly $9,581 billion by 2025. The healthcare market is growing rapidly and offers new opportunities and risks for companies in this sector and those operating in the broader healthcare value chain. Together with
(CTMS) Clinical Trial Management System Market Analysis Focusing on Top Key Play …
CTMS Market size is set to exceed USD 2.5 billion by 2025; according to a new research report by Global Market Insights. Increasing clinical trials worldwide is the key factor that will augment the global CTMS market growth during the forecast period. Initiatives by government organizations such as NIH to conduct various clinical studies for detection and prevention of diseases will favor segment growth. Moreover, presence of regulatory bodies to enforce
Global Pathology Devices Market Projections & Future Scenario Analyzed until 202 …
The global pathology devices market can be segmented on the basis of technology, application, end-users and region. On the basis of technology, it is sub-segmented into clinical chemistry, immunoassays technology, microbiology, hematology and molecular diagnostics. Molecular diagnostics is anticipated to be the fastest growing sub-segment during the forecast period. The better quality of diagnosis offered by the molecular diagnostics is anticipated to be the major factor for molecular diagnostics to